
On April 13, 2023, the Federal Trade Commission (“FTC”) announced that it has notified approximately 670 companies of potential FTC advertising regulation violations, triggering FTC authority to pursue steep civil penalties if companies fail to substantiate their product claims. The target of this crusade is companies primarily advertising over-the-counter drugs, homeopathic products, dietary supplements, and functional foods. Once on notice, companies could be subject to civil penalties of up to $50,120 per violation for unsubstantiated product claims.Continue Reading Health Product Advertisers Beware: Tidal Wave of FTC Notices Could Spawn Litigation and Hefty Fines